Allied Health, The Royal Melbourne Hospital, Parkvillle, VIC 3050, Australia.
Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC 3010, Australia.
Int J Environ Res Public Health. 2024 Jul 22;21(7):958. doi: 10.3390/ijerph21070958.
A multidisciplinary approach is required for the management of long COVID. The aim of this study was to determine the feasibility (demand, implementation, practicality, acceptability, and limited efficacy) of an allied-health-led multidisciplinary symptom management service (ReCOV) for long COVID.
A single-group observational cohort feasibility study was conducted to determine demand (referrals), acceptability (survey), implementation (waitlist times, health professions seen), practicality (adverse events), and limited efficacy (admission and discharge scores from the World Health Organization Disability Assessment Scale, Brief Illness Perception Questionnaire (BIPQ), Patient Health Questionnaire, and EuroQol 5D-5L). Data are presented as median [interquartile range] or count (percentage).
During the study, 143 participants (aged 42.00 [32.00-51.00] years, 68% women) participated in ReCOV. Participants were waitlisted for 3.86 [2.14-9.86] weeks and engaged with 5.00 [3.00-6.00] different health professionals. No adverse events occurred. The thematic analysis revealed that ReCOV was helpful but did not fully meet the needs of all participants. Limited efficacy testing indicated that participants had improved understanding and control ( < 0.001) of symptoms (BIPQ) and a small improvement in EQ VAS score (median difference 5.50 points [0.00-25.00], = 0.004]).
A multidisciplinary service was safe and mostly acceptable to participants for the management of long COVID. Further research should investigate the clinical and cost effectiveness of such a service, including optimal service duration and patient outcomes.
长新冠的管理需要多学科方法。本研究旨在确定以辅助医疗为主导的多学科症状管理服务（ReCOV）对长新冠的可行性（需求、实施、实用性、可接受性和有限疗效）。
进行了一项单组观察性队列可行性研究，以确定需求（转介）、可接受性（调查）、实施（候补名单时间、接受的健康专业人员）、实用性（不良事件）和有限疗效（世界卫生组织残疾评估量表、简短疾病感知问卷（BIPQ）、患者健康问卷和 EuroQol 5D-5L 的入院和出院评分）。数据以中位数（四分位距）或计数（百分比）呈现。
在研究期间，143 名参与者（年龄 42.00[32.00-51.00]岁，68%为女性）参加了 ReCOV。参与者候补名单时长为 3.86[2.14-9.86]周，与 5.00[3.00-6.00]名不同的健康专业人员接触。没有发生不良事件。主题分析表明，ReCOV 有帮助，但没有完全满足所有参与者的需求。有限疗效测试表明，参与者对症状（BIPQ）的理解和控制有所改善（<0.001），且 EQ VAS 评分略有提高（中位数差值 5.50 分[0.00-25.00]，=0.004）。
多学科服务对长新冠患者的管理是安全且大多数参与者可接受的。进一步的研究应调查此类服务的临床和成本效益，包括最佳服务持续时间和患者结局。
